维普中文期刊产品整合服务

Epilepsy triggered by mefloquine in an adult traveler to Uganda

查看全文 作  者:Federico [1]Gobbi;Andrea [1]Rossanese;Dora [1]Buonfrate;Andrea [1]Angheben;Chiara [2]Postiglione;Zeno [1]Bisoffi 高影响力作者 机构地区:[1]Department of Tropical Diseases, Sacro Cuore-Don Calabria Hospital, 37024 Verona, Italy;[2]Prevention Department, ULSS 20 Verona, 37122 Verona, Italy高影响力机构 出  处:《World Journal of Clinical Cases》索引2014年第2卷第1期,共4页高影响力期刊 摘  要:We report a case of a traveler who visited Uganda for 8 d, and took mefloquine one tablet/week for malaria prophylaxis. After the second dose, he suffered from two episodes of loss of consciousness with seizures, therefore mefloquine was discontinued. During the flight back after full recovery, seizures reoccurred while he was on board, he was disembarked in Addis Ababa and then transferred to Nairobi. After repatriation to Italy, he experienced four other similar episodes. The patient was still on full dose anticonvulsant therapy one year and a half after, as any attempt at reduced dose was unsuccessful. Currently, three agents(mefloquine, atovaquone/proguanil, and doxycycline) are recommended for malaria chemoprophylaxis, with similar efficacy but different adverse event profiles, regimens, and prices. Considering that mefloquine is associated with a higher risk of neurologic and psychiatric adverse events than the alternative regimens, we suggest considering mefloquine as a second line choice after atovaquone/progua-nil and doxycycline for short-term travelers. 关 键 词:MEFLOQUINE NEUROPSYCHIATRIC disorders EPILEPSY ANTIMALARIAL CHEMOPROPHYLAXIS Side effects
相关文献

参考文献(24)

引证文献(2)

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费